Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B
Clinical trial NCT03672188 · COMPLETED
Trial details
- NCT number
- NCT03672188
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2020-09-03
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.